KRAS and lung adenocarcinoma: A study by Soucek and colleagues, focusing on an endogenous Myc-switchable KrasG12D (LSL-Kras, TRE-Omomyc, and CMVrtTA) mouse model of lung adenocarcinoma showed that KrasG12D expressing mice developed bronchiolar hyperplasia [31].